To add 1000 medical representatives
Morepen Laboratories announced a bold expansion plan aimed at deepening its connection with doctors, patients, pharmacies, and healthcare professionals across the country. As part of this strategic initiative, the company will add more than 1,000 professionals to its salesforce over the next three years, with over 200 team members expected to join in FY26 alone.
Following consistently encouraging growth in the segment, this move marks a significant step in strengthening Morepen’s formulation business in the market, reinforcing its commitment to building a stronger domestic footprint and aligning with India’s vision of affordable, accessible healthcare for all.
"This expansion represents a pivotal moment in Morepen’s journey as we sharpen our focus on the expanding domestic finished dosage market," said Sushil Suri, CMD, Morepen Laboratories. "With the leadership in our high-value APIs, this significant increase in our salesforce and enhanced reach to doctors, pharmacies, and patients, we are setting the stage for getting a bigger pie in the Indian pharmaceutical market valued at Rs 2.38 lakh crore, yielding higher gross margins and better returns for stakeholders in the long run.”
Currently, Morepen’s formulation business stands at approximately Rs 325 crore, and the company is targeting a Rs 1,000 crore finished dosages business within the next five years. This goal will be supported by an aggressive expansion of its medical representative network and deeper market penetration across urban and rural India, with major growth expected from new products that the company is already producing at highly competitive costs.
